Neurocrine Biosciences awarded Chief Commercial Officer Eric Benevich 6,275 shares at $0 on September 11, 2026. A separate entry recorded his forfeiture of 3,386 shares at $156.22 per share. The transactions corresponded with reported holdings of 70,683 shares and 67,297 shares, respectively, and represented about 8.9% and 4.8% of the relevant holdings.

Key Highlights

  • Transaction code A classifies Benevich’s entry as an award or grant.
  • The awarded shares represented about 8.9% of his resulting position.
  • The forfeiture entry used transaction code F and was recorded at $156.22 per share.

NEUROCRINE BIOSCIENCES INC (NASDAQ: NBIX) awarded Chief Commercial Officer Eric Benevich 6,275 shares at $0 on September 11, 2026. A separate transaction on the same date recorded the forfeiture of 3,386 shares at $156.22 per share, with the reported holdings associated with the entries standing at 70,683 shares and 67,297 shares.

Award and Forfeiture Entries

The award was recorded under transaction code A. Benevich’s reported holding after that entry was 70,683 shares, while the awarded amount represented about 8.9% of the resulting holding. The separate 3,386-share entry used transaction code F and was recorded at $156.22 per share. Benevich’s holding after that transaction was 67,297 shares, with the forfeited amount representing about 4.8% of his prior holding. The transaction codes used here mean: A denotes an award, grant, or other Acquisition from the company; F denotes shares withheld or delivered to cover taxes or an exercise price.